Trust Company of Vermont’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $27.8M | Sell |
47,970
-24
| -0.1% | -$13.6K | 1.16% | 21 |
|
|
2025
Q3 | $23.3M | Buy |
47,994
+1,378
| +3% | +$641K | 1.01% | 24 |
|
|
2025
Q2 | $18.9M | Buy |
46,616
+126
| +0.3% | +$52.7K | 0.89% | 31 |
|
|
2025
Q1 | $23.1M | Sell |
46,490
-15
| -0% | -$8.12K | 1.15% | 20 |
|
|
2024
Q4 | $24.2M | Buy |
46,505
+3,070
| +7% | +$1.69M | 1.18% | 18 |
|
|
2024
Q3 | $26.9M | Buy |
43,435
+1,569
| +4% | +$929K | 1.35% | 18 |
|
|
2024
Q2 | $23.2M | Buy |
41,866
+1,453
| +4% | +$832K | 1.26% | 17 |
|
|
2024
Q1 | $23.5M | Buy |
40,413
+2,222
| +6% | +$1.25M | 1.31% | 17 |
|
|
2023
Q4 | $20.3M | Buy |
38,191
+557
| +1% | +$270K | 1.35% | 13 |
|
|
2023
Q3 | $19M | Buy |
37,634
+1,796
| +5% | +$957K | 1.29% | 14 |
|
|
2023
Q2 | $18.7M | Buy |
35,838
+1,153
| +3% | +$622K | 1.22% | 17 |
|
|
2023
Q1 | $20M | Buy |
34,685
+659
| +2% | +$371K | 1.4% | 13 |
|
|
2022
Q4 | $18.7M | Sell |
34,026
-24
| -0.1% | -$12.7K | 1.37% | 15 |
|
|
2022
Q3 | $17.3M | Sell |
34,050
-13
| -0% | -$7.28K | 1.37% | 14 |
|
|
2022
Q2 | $18.5M | Sell |
34,063
-425
| -1% | -$234K | 1.41% | 12 |
|
|
2022
Q1 | $20.4M | Sell |
34,488
-219
| -0.6% | -$126K | 1.38% | 12 |
|
|
2021
Q4 | $23.2M | Sell |
34,707
-318
| -0.9% | -$199K | 1.46% | 13 |
|
|
2021
Q3 | $20M | Sell |
35,025
-207
| -0.6% | -$114K | 1.42% | 13 |
|
|
2021
Q2 | $17.8M | Buy |
35,232
+693
| +2% | +$327K | 1.24% | 17 |
|
|
2021
Q1 | $15.8M | Buy |
34,539
+540
| +2% | +$258K | 1.18% | 18 |
|
|
2020
Q4 | $15.8M | Sell |
33,999
-701
| -2% | -$329K | 1.26% | 17 |
|
|
2020
Q3 | $15.3M | Buy |
34,700
+120
| +0.3% | +$49.6K | 1.4% | 11 |
|
|
2020
Q2 | $12.5M | Sell |
34,580
-5,743
| -14% | -$1.92M | 1.24% | 17 |
|
|
2020
Q1 | $11.4M | Buy |
40,323
+961
| +2% | +$303K | 1.07% | 30 |
|
|
2019
Q4 | $12.8M | Sell |
39,362
-688
| -2% | -$209K | 0.96% | 33 |
|
|
2019
Q3 | $11.7M | Sell |
40,050
-42
| -0.1% | -$12K | 0.94% | 38 |
|
|
2019
Q2 | $11.8M | Sell |
40,092
-637
| -2% | -$175K | 0.98% | 34 |
|
|
2019
Q1 | $11.1M | Sell |
40,729
-100
| -0.2% | -$24.9K | 0.96% | 33 |
|
|
2018
Q4 | $9.14M | Buy |
40,829
+639
| +2% | +$150K | 0.88% | 37 |
|
|
2018
Q3 | $9.81M | Buy |
40,190
+358
| +0.9% | +$82.4K | 0.83% | 39 |
|
|
2018
Q2 | $8.25M | Buy |
39,832
+2,000
| +5% | +$425K | 0.74% | 49 |
|
|
2018
Q1 | $7.81M | Sell |
37,832
-20
| -0.1% | -$4.2K | 0.74% | 46 |
|
|
2017
Q4 | $7.19M | Buy |
37,852
+167
| +0.4% | +$32K | 0.67% | 51 |
|
|
2017
Q3 | $7.13M | Buy |
37,685
+450
| +1% | +$81.5K | 0.71% | 48 |
|
|
2017
Q2 | $6.5M | Buy |
37,235
+1,684
| +5% | +$283K | 0.67% | 52 |
|
|
2017
Q1 | $5.46M | Buy |
35,551
+249
| +0.7% | +$38.1K | 0.59% | 57 |
|
|
2016
Q4 | $4.98M | Buy |
35,302
+311
| +0.9% | +$45.9K | 0.57% | 56 |
|
|
2016
Q3 | $5.57M | Buy |
34,991
+194
| +0.6% | +$29.9K | 0.7% | 46 |
|
|
2016
Q2 | $5.14M | Buy |
34,797
+249
| +0.7% | +$36.8K | 0.68% | 50 |
|
|
2016
Q1 | $4.89M | Buy |
34,548
+914
| +3% | +$122K | 0.68% | 48 |
|
|
2015
Q4 | $4.77M | Buy |
33,634
+1,417
| +4% | +$189K | 0.68% | 50 |
|
|
2015
Q3 | $3.94M | Buy |
32,217
+2,512
| +8% | +$327K | 0.61% | 56 |
|
|
2015
Q2 | $3.85M | Buy |
29,705
+1,714
| +6% | +$223K | 0.56% | 55 |
|
|
2015
Q1 | $3.76M | Buy |
27,991
+542
| +2% | +$69.9K | 0.55% | 58 |
|
|
2014
Q4 | $3.44M | Sell |
27,449
-633
| -2% | -$77K | 0.5% | 64 |
|
|
2014
Q3 | $3.42M | Sell |
28,082
-284
| -1% | -$34.5K | 0.52% | 60 |
|
|
2014
Q2 | $3.35M | Buy |
28,366
+17
| +0.1% | +$2K | 0.52% | 59 |
|
|
2014
Q1 | $3.41M | Sell |
28,349
-934
| -3% | -$111K | 0.56% | 54 |
|
|
2013
Q4 | $3.26M | Buy |
29,283
+74
| +0.3% | +$7.36K | 0.55% | 58 |
|
|
2013
Q3 | $2.69M | Buy |
29,209
+328
| +1% | +$29.7K | 0.49% | 68 |
|
|
2013
Q2 | $2.44M | Buy |
+28,881
| New | +$2.4M | 0.48% | 71 |
|
Other funds holding TMO
JSC
Trust Company of Vermont's TMO Position: Q4 2025 in Review
Trust Company of Vermont reduced its Thermo Fisher Scientific (TMO) stake by 0.05% in Q4 2025, selling an estimated $13.6K and leaving 47,970 shares worth $27.8M. The position accounts for 1.16% of the portfolio, ranked #21.
Trust Company of Vermont first reported a position in TMO in Q2 2013 and has held it in 51 quarters since. 2,700 funds tracked by Wall St. Rank hold TMO as of Q4 2025.
- Trust Company of Vermont held 47,970 shares of Thermo Fisher Scientific worth $27.8M as of Q4 2025.
- Trust Company of Vermont sold 24 Thermo Fisher Scientific shares in Q4 2025, an estimated $13.6K.
- Thermo Fisher Scientific made up 1.16% of Trust Company of Vermont's portfolio in Q4 2025, its #21 holding.
- Trust Company of Vermont first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 51 quarters since.
- 2,700 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.
Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.